Starting in November, the Hong Kong government plans to provide influenza vaccines to high-risk groups such as health-care workers, the elderly, and the disabled.

Speaking at a media briefing last week, Hong Kong\'s new Director of Health, Lam Ping-yan, said that influenza jabs would be given to all health-care workers and to about 59 000 elderly and 10 000 disabled people. He explained the reasoning behind this initiative: "Hopefully, if SARS \[severe acute respiratory syndrome\] actually comes back we will be able to distinguish between SARS and influenza because of the widespread vaccine programme."

As the SARS outbreak now appears to be drawing to a close, public-health officials are focusing on potential problems that may arise during the next flu season, when influenza is likely to raise suspicion of SARS. Due to possible confusion, WHO recommends that health-care workers in all countries be immunised against influenza ([www.who.int/csr/don/2003_07_03/en/](http://www.who.int/csr/don/2003_07_03/en/)).

Typically, during seasonal epidemics, the influenza virus can infect 10--20% of the total global population, which could result in more than 3 million cases of severe illness, with up to half a million deaths. Health-care systems confronted with these numbers of influenza cases that could also be SARS cases would be completely overburdened and unable to undertake the required isolation, contact tracing, and quarantine of suspected SARS patients.

But is it enough to immunise only health-care workers and other vulnerable populations? Some experts argue that compulsory flu immunisation for the majority of citizens may be more appropriate than just targeting high-risk groups. Commenting on the possibility of mass vaccination campaigns, Annelies Wilder-Smith (Tan Tock Seng Hospital, Singapore), told *The Lancet* that "broad coverage is needed; you want to keep all influenza cases to a minimum to reduce differential SARS diagnoses".

Flu vaccination as a public health preventive measure may be applicable in SARS risk areas globally, but particularly in regions designated "potential zones of re-emergence of SARS" and "nodal areas", as defined recently in a WHO document on the management of SARS in the post-outbreak period ([www.who.int/csr/sars/postoutbreak/en](http://www.who.int/csr/sars/postoutbreak/en)).

Influenza may resemble SARS, and pneumonia can be a feature of both diseases, which have highest mortality rates in people aged 65 years and over, and in those with comorbid conditions. To date, no simple diagnostic test is available to rule out SARS early in the course of the illness.
